Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with

Anjali S Vekaria1, Patrick M Brunner2, Ahmad I Aleisa1

  • 1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

F1000Research
|December 5, 2017
PubMed

Insights

C-reactive protein (CRP) is elevated in moderate-to-severe atopic dermatitis (AD), correlating with disease severity and indicating increased cardiovascular risk in these patients.

Area of Science:

  • Dermatology
  • Immunology
  • Cardiovascular Health

Background:

  • Atopic dermatitis (AD) is a common chronic inflammatory skin condition with systemic implications.
  • Emerging evidence suggests a link between systemic inflammation in AD and increased cardiovascular disease risk.

Purpose of the Study:

  • To investigate C-reactive protein (CRP) levels in patients with moderate-to-severe AD.
  • To assess the correlation between CRP levels and clinical disease severity (SCORAD, BSA).
  • To evaluate CRP as a potential marker for systemic inflammation and cardiovascular risk in AD.

Main Methods:

  • Serum CRP levels were measured in 59 patients with moderate-to-severe AD and compared to 118 matched healthy controls from NHANES.
  • Clinical severity was assessed using SCORing of Atopic Dermatitis (SCORAD) and body surface area (BSA).
  • Correlations between CRP, SCORAD, BSA, IgE, and LDH levels were analyzed.

Main Results:

  • AD patients exhibited significantly higher serum CRP levels compared to controls (p=0.001).
  • Elevated CRP levels (>0.3mg/dl) were observed in 52.5% of AD patients, suggesting high cardiovascular risk.
  • CRP levels showed significant positive correlations with both SCORAD (r=0.427, p=0.0008) and BSA (r=0.407, p=0.0015).
  • Elevated IgE and LDH levels were noted in AD patients, but correlations with disease severity and CRP were weak or non-significant.

Conclusions:

  • C-reactive protein (CRP) is a reliable marker for disease severity in moderate-to-severe atopic dermatitis.
  • The findings support the concept of AD as a systemic disease with associated chronic inflammation.
  • Elevated CRP in AD patients highlights potential cardiovascular risks that warrant further investigation.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
711
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
21
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
22